4/A//SEC Filing
Vivaldi Coelho Rogerio 4/A
Accession 0001209191-22-022681
CIK 0001658247other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 7:08 PM ET
Size
5.9 KB
Accession
0001209191-22-022681
Insider Transaction Report
Form 4/AAmended
Vivaldi Coelho Rogerio
Director
Transactions
- Award
Stock Option (right to buy)
2022-01-03+35,000→ 35,000 totalExercise: $28.31Exp: 2031-12-31→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]On January 10, 2022, the reporting person filed a Form 4 which inadvertently reported that he was granted an option to purchase 25,000 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person was granted an option to purchase 35,000 shares of common stock.
- [F2]The option shall vest and become exercisable in three substantially equal annual installments on each of the first three anniversaries of the date of grant, subject to continued service as a director through each such vesting date.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001610381
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 7:08 PM ET
- Size
- 5.9 KB